GeneDx Holdings WGS paid Red+blue Strategies $80K for lobbying in Q2 2026 · Health Issues, Medicare

Trade details

Type: Lobbying report
Amount: $80,000
Quarter: Q2 2026
Stock: GeneDx Holdings WGS
Client: Genedx
Reported: 26/07/17

Up 0.0% from last quarter

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Genedx's other lobbying reports

Genedx
LobbyingGeneDx Holdings
Lobbying
GeneDx Holdings
WGS
$80K
$80K
Reported 04/20
for Q1
Genedx
LobbyingGeneDx Holdings
Lobbying
GeneDx Holdings
WGS
$80K
$80K
Reported 01/20
for Q4 2025
Genedx
LobbyingGeneDx Holdings
Lobbying
GeneDx Holdings
WGS
$80K
$80K
Reported 25/10/11
for Q3 2025
Genedx
LobbyingGeneDx Holdings
Lobbying
GeneDx Holdings
WGS
$80K
$80K
Reported 25/07/17
for Q2 2025
Genedx
LobbyingGeneDx Holdings
Lobbying
GeneDx Holdings
WGS
$17.5K
$17.5K
Reported 23/05/15
for Q2 2022

GeneDx Holdings WGS paid Red+blue Strategies $80K for lobbying in Q2 2026 · Health Issues, Medicare | Whalegun